Citing limitations in the study, Novo Nordisk, which makes the drugs included in the claims analysis, said in a statement reported by Reuters that it does not believe these data are sufficient to draw conclusions about overall patient adherence and persistence to various GLP-1 medicines, including our treatments. Nonetheless, the problem of lack of patient persistence on GLP-1s under real-world conditions, examined and published by a growing number of sources, isnt going away
Meanwhile, those on alternative treatments achieved an impressive 10% weight loss within the same timeframe
Some patients find that meals high in fatsuch as fried foods, creamy sauces, or fatty meatstrigger nausea or simply lose their appeal
This policy ensures you receive treatments like semaglutide and tirzepatide with confirmed quality, potency, and regulatory oversight, giving you peace of mind and effective results